Foscarnet Sodium

CHEMBL754 Phase 4 Approuvé Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
192.0 g/mol
LogP
Phase
4

This sodium salt form of foscarnet is an intravenous antiviral used to treat serious viral infections in immunocompromised patients, particularly cytomegalovirus retinitis and acyclovir-resistant herpes infections. It must be given with adequate hydration to protect the kidneys from toxicity.

Masse moléculaire

191,9500 g/mol

TPSA

103,00 Ų

Aires thérapeutiques

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Structure 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

O=C([O-])P(=O)([O-])[O-].[Na+].[Na+].[Na+]

InChI

InChI=1S/CH3O5P.3Na/c2-1(3)7(4,5)6;;;/h(H,2,3)(H2,4,5,6);;;/q;3*+1/p-3

Molecular Formula

CNa3O5P

HBD / HBA

- / 5

Liaisons Rotatives

0

Atomes Lourds

10

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Foire aux questions

This sodium salt form of foscarnet is an intravenous antiviral used to treat serious viral infections in immunocompromised patients, particularly cytomegalovirus retinitis and acyclovir-resistant herpes infections. It must be given with adequate hydration to protect the kidneys from toxicity.

Yes, Foscarnet Sodium is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL754. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 44561. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Avertissement médical

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.